格隆汇10月23日丨歌礼制药-B(01672.HK)公告，10月23日耗资180.30万港元回购20万股，每股回购价 8.86-9.2港元。 ...

智通财经APP讯，歌礼制药-B(01672)发布公告，于2025年10月23日斥资180.3万港元回购20万股。 ...

歌礼制药-B(01672)发布公告，于2025年10月23日斥资180.3万港元回购20万股。 ...

FF305 | 1). | 購回股份擬註銷但尚未註銷 | | 150,000 | 0.0151 % | HKD | 6.4567 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年4月3日 | | | | | | 2). | 購回股份擬註銷但尚未註銷 | | 150,000 | 0.0151 % | HKD | 5.0924 | | | 變動日期 | 2025年4月7日 | | | | | | 3). | 購回股份擬註銷但尚未註銷 | | 100,000 | 0.0101 % | HKD | 4.8531 | | | 變動日期 | 2025年4月9日 | | | | | | 4). | 購回股份擬註銷但尚未註銷 | | 100,000 | 0.0101 % | HKD | 4.9125 | | | 變動日期 | 2025年4月10日 | | | | | | 5). | 購回股份擬註銷但尚未註銷 | | 100,000 | 0.0101 % | HKD | 5.3339 | | | 變動日期 | 2025年4月11日 | | | | | ...

Core Viewpoint - On October 22, 35 Hong Kong-listed companies conducted share buybacks, totaling 10.4965 million shares and an amount of 52.7745 million HKD [1][2]. Group 1: Buyback Details - The company with the highest buyback amount on October 22 was AAC Technologies, with a buyback amount of 11.9098 million HKD for 300,000 shares [1][2]. - Linklogis Technology-W followed with a buyback of 2.430 million shares, amounting to 7.4708 million HKD [1][2]. - Mengniu Dairy repurchased 500,000 shares for 7.1714 million HKD [1][2]. Group 2: Year-to-Date Buyback Totals - AAC Technologies has conducted multiple buybacks this year, with a cumulative buyback amount of 858.628 million HKD [2]. - Linklogis Technology-W's total buyback amount for the year reached 225.0668 million HKD [2]. - Mengniu Dairy's year-to-date buyback amount stands at 45.832 million HKD [2]. Group 3: Buyback Volume Rankings - The highest number of shares repurchased on October 22 was by Linklogis Technology-W, with 2.43 million shares [1][2]. - Other notable buybacks in terms of volume included MorningX Technology with 1.064 million shares and China Hengyou Group with 1 million shares [1][2].

Summary of Key Points Core Viewpoint - A total of 30 companies, including major players like 瑞声科技 (AAC Technologies) and 蒙牛乳业 (Mengniu Dairy), conducted share buybacks on October 22, 2025, indicating a trend of companies returning capital to shareholders amidst market conditions. Group 1: Buyback Details - 瑞声科技 (AAC Technologies) had the largest buyback amount, repurchasing 300,000 shares for a total of 11.90 million yuan [1] - 联易融科技-W (Lianyi Technology) repurchased 2.43 million shares, totaling 7.47 million yuan, representing 3.288% of its total share capital [2] - 蒙牛乳业 (Mengniu Dairy) bought back 500,000 shares for 7.17 million yuan, which is 0.517% of its total share capital [2] Group 2: Other Notable Buybacks - 康臣药业 (Kangchen Pharmaceutical) repurchased 283,000 shares for 4.33 million yuan, accounting for 7.969% of its total share capital [2] - 连连数字 (Lianlian Digital) bought back 440,000 shares for 3.54 million yuan, which is 0.138% of its total share capital [2] - 固生堂 (Gushengtang) repurchased 91,300 shares for 2.75 million yuan, representing 2.076% of its total share capital [2] Group 3: Additional Companies Involved - 绿城服务 (Greentown Service) repurchased 216,000 shares for 989,300 yuan, which is 0.007% of its total share capital [2] - 歌礼制药-B (Galactico Pharmaceutical) bought back 100,000 shares for 926,500 yuan, accounting for 0.068% of its total share capital [2] - 医渡科技 (Yidu Technology) repurchased 17,700 shares for 99,800 yuan, representing 0.330% of its total share capital [2]

歌礼制药-B(01672)公布，2025年10月22日耗资约92.65万港元回购10万股股份。 ...

Core Viewpoint - The company, Gilead Sciences-B (01672.HK), announced a share buyback of 100,000 shares at a cost of HKD 927,000 on October 22 [1] Summary by Category - **Company Actions** - Gilead Sciences-B has executed a buyback of 100,000 shares, indicating a commitment to returning value to shareholders [1]

第 1 頁 共 7 頁 v 1.3.0 | 1). | 購回股份擬註銷但尚未註銷 | | 150,000 | 0.0151 % | HKD | 6.4567 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年4月3日 | | | | | | 2). | 購回股份擬註銷但尚未註銷 | | 150,000 | 0.0151 % | HKD | 5.0924 | | | 變動日期 | 2025年4月7日 | | | | | | 3). | 購回股份擬註銷但尚未註銷 | | 100,000 | 0.0101 % | HKD | 4.8531 | | | 變動日期 | 2025年4月9日 | | | | | | 4). | 購回股份擬註銷但尚未註銷 | | 100,000 | 0.0101 % | HKD | 4.9125 | | | 變動日期 | 2025年4月10日 | | | | | | 5). | 購回股份擬註銷但尚未註銷 | | 100,000 | 0.0101 % | HKD | 5.3339 | | | 變動日期 | 2025年4月 ...

消息面上，歌礼制药今早发布公告，其小分子GLP-1受体(GLP-1R)激动剂ASC30治疗肥胖症的每月一次 皮下储库型(depot)制剂(治疗制剂)的美国IIa期研究(NCT06679959)已于近期完成受试者入组。65例受试 者均为肥胖人群或伴有至少一种体重相关合并症的超重人群。 歌礼制药-B(01672)涨超4%，截至发稿，涨4.18%，报9.47港元，成交额265.58万港元。 ASC30每月一次皮下储库型治疗制剂的IIa期研究是一项在美国开展的、为期12周、随机、双盲、安慰 剂对照及多中心的临床研究，旨在评估其在肥胖受试者(体重指数(BMI)≥30kg/m2)或伴有至少一种体重 相关合并症的超重受试者(27kg/m2≤BMI<30kg/m2)中的安全性、耐受性和疗效。该研究分为不同剂量的 三个队列，共计65名受试者。预计将于2026年第一季度获得顶线数据。 ...